"It pains me to think I won't be able to fully see my grandchildren's faces and fully experience the biggest moments of my loved ones' lives.''"
Recent lawsuits have surfaced against Novo Nordisk, the maker of the weight-loss drugs Ozempic and Wegovy, filed by a grandmother and a New Jersey man, both claiming they suffered permanent vision loss after using the medication. The plaintiffs allege that the company failed to disclose the serious risk of irreversible blindness associated with these GLP-1 obesity drugs. Despite their popularity and significant sales, they argue that the drugmaker has been deceptive and misleading regarding the true dangers involved, including doubling the risk of an eye stroke that can lead to sight loss.
Read at New York Post
Unable to calculate read time
Collection
[
|
...
]